DRW Securities’s Boston Scientific BSX Stock Holding History

DRW Securities’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79M	Buy	+28,600	New	+$2.29M	0.02%	223

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DRW Securities's BSX Position: Q1 2026 in Review

DRW Securities increased its Boston Scientific (BSX) stake by 630% in Q1 2026, buying an estimated $2.34M and bringing the position to 33,916 shares worth $2.13M. The position accounts for 0.03% of the portfolio, ranked #203.

DRW Securities first reported a position in BSX in Q4 2017 and has held it in 12 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

DRW Securities held 33,916 shares of Boston Scientific worth $2.13M as of Q1 2026.
DRW Securities bought 29,267 Boston Scientific shares in Q1 2026, an estimated $2.34M.
Boston Scientific made up 0.03% of DRW Securities's portfolio in Q1 2026, its #203 holding.
DRW Securities first reported a position in Boston Scientific in Q4 2017 and has held it in 12 quarters since.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.